These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31285695)

  • 1. Cost-effectiveness analysis of newborn pulse oximetry screening to detect critical congenital heart disease in Colombia.
    Londoño Trujillo D; Sandoval Reyes NF; Taborda Restrepo A; Chamorro Velasquez CL; Dominguez Torres MT; Romero Ducuara SV; Troncoso Moreno GA; Aranguren Bello HC; Fonseca Cuevas A; Bermudez Hernandez PA; Sandoval Trujillo P; Dennis RJ
    Cost Eff Resour Alloc; 2019; 17():11. PubMed ID: 31285695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse oximetry screening for critical congenital heart defects.
    Plana MN; Zamora J; Suresh G; Fernandez-Pineda L; Thangaratinam S; Ewer AK
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011912. PubMed ID: 29494750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse oximetry screening for critical congenital heart defects in Ontario, Canada: a cost-effectiveness analysis.
    Mukerji A; Shafey A; Jain A; Cohen E; Shah PS; Sander B; Shah V
    Can J Public Health; 2020 Oct; 111(5):804-811. PubMed ID: 31907759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.
    Knowles R; Griebsch I; Dezateux C; Brown J; Bull C; Wren C
    Health Technol Assess; 2005 Nov; 9(44):1-152, iii-iv. PubMed ID: 16297355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China.
    Tobe RG; Martin GR; Li F; Moriichi A; Wu B; Mori R
    Medicine (Baltimore); 2017 Nov; 96(46):e8683. PubMed ID: 29145300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.
    Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH
    Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis.
    Roberts TE; Barton PM; Auguste PE; Middleton LJ; Furmston AT; Ewer AK
    Arch Dis Child; 2012 Mar; 97(3):221-6. PubMed ID: 22247242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.
    Ewer AK; Furmston AT; Middleton LJ; Deeks JJ; Daniels JP; Pattison HM; Powell R; Roberts TE; Barton P; Auguste P; Bhoyar A; Thangaratinam S; Tonks AM; Satodia P; Deshpande S; Kumararatne B; Sivakumar S; Mupanemunda R; Khan KS
    Health Technol Assess; 2012; 16(2):v-xiii, 1-184. PubMed ID: 22284744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
    Peterson C; Grosse SD; Glidewell J; Garg LF; Van Naarden Braun K; Knapp MM; Beres LM; Hinton CF; Olney RS; Cassell CH
    Public Health Rep; 2014; 129(1):86-93. PubMed ID: 24381364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn pulse oximetry screening for critical congenital heart defects.
    Jullien S
    BMC Pediatr; 2021 Sep; 21(Suppl 1):305. PubMed ID: 34496777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge.
    Narayen IC; Te Pas AB; Blom NA; van den Akker-van Marle ME
    Eur J Pediatr; 2019 Jan; 178(1):97-103. PubMed ID: 30334077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Pulse Oximetry Screening for Critical Congenital Heart Defects after Home Birth and Early Postnatal Discharge.
    Narayen IC; Blom NA; van Geloven N; Blankman EIM; van den Broek AJM; Bruijn M; Clur SB; van den Dungen FA; Havers HM; van Laerhoven H; Mir SE; Muller MA; Polak OM; Rammeloo LAJ; Ramnath G; van der Schoor SRD; van Kaam AH; Te Pas AB;
    J Pediatr; 2018 Jun; 197():29-35.e1. PubMed ID: 29580679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.
    Grosse SD; Peterson C; Abouk R; Glidewell J; Oster ME
    Int J Neonatal Screen; 2017; 3(4):34. PubMed ID: 29376140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn Screening for Critical Congenital Heart Disease in a Low-Resource Setting; Research Protocol and Preliminary Results of the Tanzania Pulse Oximetry Study.
    Majani N; Chillo P; Slieker MG; Sharau G; Mlawi V; Mongella S; Nkya D; Khuboja S; Kwesigabo G; Kamuhabwa A; Janabi M; Grobbee D
    Glob Heart; 2022; 17(1):32. PubMed ID: 35837363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oximetry and neonatal examination for the detection of critical congenital heart disease: a systematic review and meta-analysis.
    Aranguren Bello HC; Londoño Trujillo D; Troncoso Moreno GA; Dominguez Torres MT; Taborda Restrepo A; Fonseca A; Sandoval Reyes N; Chamorro CL; Dennis Verano RJ
    F1000Res; 2019; 8():242. PubMed ID: 31372214
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP.
    Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ; ;
    Pediatrics; 2009 Aug; 124(2):823-36. PubMed ID: 19581259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal pulse oximetry screening improves detecting of critical congenital heart disease.
    Ma XJ; Huang GY
    Chin Med J (Engl); 2013 Jul; 126(14):2736-40. PubMed ID: 23876906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: a probabilistic cost-effectiveness model and value of information analysis.
    Griebsch I; Knowles RL; Brown J; Bull C; Wren C; Dezateux CA
    Int J Technol Assess Health Care; 2007; 23(2):192-204. PubMed ID: 17493305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics.
    Mahle WT; Newburger JW; Matherne GP; Smith FC; Hoke TR; Koppel R; Gidding SS; Beekman RH; Grosse SD; ;
    Circulation; 2009 Aug; 120(5):447-58. PubMed ID: 19581492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Position Statement on Pulse Oximetry Screening in Newborns to Enhance Detection of Critical Congenital Heart Disease.
    Wong KK; Fournier A; Fruitman DS; Graves L; Human DG; Narvey M; Russell JL
    Can J Cardiol; 2017 Feb; 33(2):199-208. PubMed ID: 28043739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.